Month: February 2025

Nanterre, 10th February 2025 Publication of audited consolidated financial statements at 31 December 2024 VINCI announces the publication of its consolidated financial statements at 31 December 2024 (financial statements and notes) accompanied by the report of the statutory auditors on the consolidated financial statements. The audited consolidated statements at 31 December 2024 and the report on the financial statements for 2024 are available in English and French on the Group’s website: https://www.vinci.com/en/finance/investors/regulatory-information/reports-and-presentations About VINCIVINCI is a global player in concessions, energy and construction, employing 285,000 people in more than 120 countries. We design, finance, build and operate infrastructure and facilities that help improve daily life and mobility for all. Because we...

The Board of Directors of Festi hf. hereby announces that the Annual General Meeting of the company will be held on Wednesday March 5, 2025, at 10.00 at the Company’s headquarters at Dalvegur 10 – 14, Kópavogur. Enclosed is the notice of the Annual General Meeting with its’ agenda, proposals for the meeting, Remuneration Policy and the reports of the Remuneration Committee and the Nomination Committee. Further information regarding the Annual General Meeting and documents can be accessed on the Company’s website: https://www.festi.is/en/vidburdir/agm-2025   For further information please contact Ásta S. Fjeldsted, CEO of Festi hf. (asta@festi.is) AttachmentsFesti hf. – Notice of AGM 2025Festi hf. – Dagskrá og tillögur fyrir aðalfund 5. mars 2025Festi hf. – Starfskjarastefna...

TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Montero Mining and Exploration Ltd. (TSX-V: MON) (“Montero” or the “Company”) is pleased to confirm that US$8,000,000 in cash (the “Second Instalment Funds”) have been received by the Company’s legal representatives from the United Republic of Tanzania (“Tanzania”). The Second Instalment represents the second instalment of the US$27,000,000 settlement between the Company and Tanzania in connection with Tanzania’s expropriation of Montero’s Wigu Hill rare earth element project (the “Expropriation”), as previously announced on 20th November 2024. The final instalment of US$7,000,000 (the “Final Instalment”) is due to be paid on or before 28th February 2025. The final net proceeds to be received by the Company is not certain at this time as final legal costs and other expenses Montero incurred...

REGULATED INFORMATION Neuilly-sur-Seine, France – February 10, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau VeritasDate Number of shares (1) Number of voting rights31/01/2025 454,179,820             Theoretical number of voting rights: 584,046,967            Number of exercisable voting rights: 578,793,786(1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2025, if any.                                 Bureau Veritas Head Office Tel: + 33 (0)1 55 24 70 00Société Anonyme Immeuble Newtime Fax: + 33 (0)1 55 24 70 01(Limited liability corporation) 40/52 boulevard du Parc www.bureauveritas.comShare capital of EUR 54,464,582.40 92200 Neuilly-sur-Seine...

PRESS RELEASE Arcueil, February 10, 2025 Declaration of transactions on own shares conducted from February 03 to February 07, 2025 Within the framework of the authorizations granted by the General Assembly on February 9, 2024 and February 4, 2025, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from February 03 to February 07, 2025 (excluding the liquidity contract):Name of the issuer Issuer identifier code Transaction date Financial instrument identifier code Total daily volume (in number of shares) Daily weighted average purchase price of shares MarketAramis Group 9695002Q984W0T41WB42 2025-02-03 FR0014003U94 12,701 7.5334 XPARAramis Group 9695002Q984W0T41WB42 2025-02-04...

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. CALGARY, Alberta, Feb. 10, 2025 (GLOBE NEWSWIRE) — Alaris Equity Partners Income Trust (“Alaris” or the “Trust“) (TSX: AD.UN) is pleased to announce that it will release its year-end results for the period ended December 31, 2024 following the closing of regular trading on the Toronto Stock Exchange Monday, March 10, 2025. Alaris management will host a conference call at 9 am MT (11am ET) the following day, Tuesday, March 11, 2025 to discuss the financial results and outlook for the Trust. Participants must register for the call using this link: Pre-registration to Q4 to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended...

In compliance with share buyback regulations, in particular Regulation (EU) 2016/1052, SPIE discloses the following transactions completed from 03 February 2025 to 09 February 2025 under the share buyback programme authorised by the 10th resolution of the SPIE general shareholders’ meeting held on 3 May 2024 and announced on 9 January 2025: Aggregate disclosure per day and per marketName of the issuer Identity code of the Issuer (LEI) Day of transaction ISIN Code Total daily volume (in number of shares) Daily weighted average price of the purchased shares (in euros) Market (MIC Code)SPIE 969500TJNS5GSFWJ8X85 03/02/2025 FR0012757854 53 000 31.6632 XPARSPIE 969500TJNS5GSFWJ8X85 03/02/2025 FR0012757854 22 076 31.6803 CEUX  Total daily volume (in number of shares) Daily weighted average price of the purchased shares (in...

Foresight VCT PLCLEI: 213800GNTY699WHACF46 CORRECTION: Issue of EquityAllotment of Ordinary Shares10 February 2025 Foresight VCT Plc (the “Company”) wishes to notify the correction of errors to the allotment figure and total number of shares in the announcement dated 10 February 2025 concerning the allotment of shares on 7 February 2025 under the offer for subscription contained in the prospectus issued by the Company dated 10 December 2024. The corrected details are as follows: The Board of Foresight VCT plc (“the Company”) is pleased to announce that 15,140,285 Ordinary Shares of 1p each in the capital of the Company (“the Shares”) were allotted on 7 February 2025 pursuant to the offer for subscription (“the Offer”) contained in the prospectus issued by the Company dated 10 December 2024. The Shares were issued at offer prices based...

FDA RMAT designation follows positive proof-of-concept U.S. clinical data from the NXC-201 NEXICART-2 clinical trial in relapsed/refractory AL Amyloidosis RMAT designation potentially streamlines the path to market approval by allowing frequent interactions with FDA and routes to FDA Accelerated Approval and Priority Review Enrollment in NEXICART-2 study accelerating; next update planned for H1 2025LOS ANGELES,CA, Feb. 10, 2025 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL amyloidosis and select immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of relapsed/refractory AL...